Lin Xie, Dejin Zang, Jianmin Yang, Fei Xue, Wenhai Sui, Yun Zhang, & Yun Zhang. (2024). Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy. Frontiers Media S.A..
Chicago Style (17th ed.) CitationLin Xie, Dejin Zang, Jianmin Yang, Fei Xue, Wenhai Sui, Yun Zhang, and Yun Zhang. Combination of ADAM17 Knockdown with Eplerenone Is More Effective than Single Therapy in Ameliorating Diabetic Cardiomyopathy. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationLin Xie, et al. Combination of ADAM17 Knockdown with Eplerenone Is More Effective than Single Therapy in Ameliorating Diabetic Cardiomyopathy. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.